Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net loss	$ (7,613,777)	$ (4,369,735)
Adjustment to reconcile net loss to net cash used in operating activities:
Stock based compensation	721,200	607,622
Changes in operating assets and liabilities:
Prepaid assets	491,273	(15,025)
Accounts payable	274,255	(60,812)
Net cash used in operating activities	(6,127,049)	(3,837,950)
Cash flows from investing activities:
Net cash from investing activities
Cash flows from financing activities:
Proceeds from issuance of preferred stock		7,208,393
Net cash from financing activities		7,208,393
Effect of exchange rate changes on cash and cash equivalents	(43,768)
Net change in cash and cash equivalents	(6,170,817)	3,370,443
Cash and cash equivalents at beginning of period	28,094,936	10,261,671
Cash and cash equivalents at end of period	21,924,119	13,632,114
Supplemental disclosure of non-cash investing and financing activities:
Accrued offering costs		17,158
Accrued dividend		$ 510,240
Issuance of common stock for accrued research and development expense	$ 1,132,013